Plant-derived estrogenic compounds, known as phytoestrogens, have drawn attention due to their potential therapeutic use. From epidemiologic data, Asian people, who frequently consume phytoestrogen-rich diets such as soybean, have been found to have a lower rate of osteoporotic fractures, cardiovascular diseases, postmenopausal symptoms (PMS), and certain cancers than Western populations.
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Sesquiterpenoid xanthorrhizol, a major bioactive compound isolated from Curcuma xanthorrhiza ROXB. commonly known as Javanese turmeric, has often been cited for its great potential in food and medical applications. Xanthorrhizol has been shown to exert antioxidant, 15, 16) anti-inflammatory, 16, 17) antibacterial, 18) neuroprotective, 19) nephroprotective, 20) and hepatoprotective activity. 21, 22) Furthermore, xanthorrhizol has been shown to have efficacy as a tumor chemopreventive agent. Xanthorrhizol was shown to suppress 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated tumor promotion in mouse skin cells 22) and attenuate lung metastasis in an in vivo model. 23) In HeLa cervical cancer cells, p53 and bax-dependent apoptosis were stimulated with xanthorrhizol treatment 24) while in MCF-7 breast cancer cells apoptosis was modulated through bcl-2, p53, and poly(ADP-ribose)polymerase-1 (PARP-1). 25) In another study using HepG2 hepatoma cells, xanthorrhizol induced the cells to undergo apoptosis via the mitochondrial pathway. 26) In addition, it has been reported that the combination of xanthorrhizol and curcumin promoted apoptosis in MDA-MB-231 breast cancer cells. 27) In the present study, using the Gal4/ERs ligand-binding transactivation assay, we examined whether xanthorrhizol might possess an estrogenic activity. It was hoped that this assay would provide further information regarding xanthorrhizol and its benefit as a phytoestrogen. The assay was conducted in transiently-transfected ER-negative COS-7 cells using both subtypes of ERs, ERa and ERb, and ligand binding domains (LBD). To determine if xanthorrhizol could induce endogenous ER-estrogen response element (ERE) interaction in cells, a further ligand binding assay was conducted in ER-positive MCF-7 cells. In parallel, pS2 mRNA analysis was performed to investigate whether xanthorrhizol could promote ER target gene expression (pS2) in MCF-7 cells. The ER antagonist, ICI 182780, was used as a method of confirmation.
MATERIALS AND METHODS

Plant Material
Dried rhizomes of C. xanthorrhiza ROXB. were collected in Jakarta, Indonesia, and identified by Dr. Nam-In Baek, Department of Oriental Medicinal Materials and Processing, Kyunghee University (Yongin, Korea). A voucher specimen (H015) has been deposited in the Department of Biotechnology, Yonsei University (Seoul, Korea). Xanthorrhizol isolated from C. xanthorrhiza was dissolved in 100% (v/v) dimethyl sulfoxide (DMSO).
Isolation of Xanthorrhizol Xanthorrhizol (Fig. 1) was isolated from the ethyl acetate fraction of the methanol ex-tract of C. xanthorrhiza ROXB., as described previously. 18) Briefly, the dried rhizomes of C. xanthorrhiza (100 g) were ground and extracted with 75% MeOH (v/v; 400 ml). The methanol extract was fractionated consecutively with ethyl acetate, n-butanol, and water. The yield at each step was 4.8, 1.7, and 1.1 g, respectively. The ethyl acetate fraction was separated chromatographically by applying the fraction to a silica gel column (70-230 mesh, Merck & Co., Whitehouse Station, NJ, U.S.A.) and eluting with an n-hexane-ethyl acetate solution (10 : 1, v/v). The final product, xanthorrhizol, was obtained as a single compound with a yield of 0.2 g.
Cell Cultures African green monkey kidney cells, COS-7, and human breast cancer cells, MCF-7, were obtained from the American Type Culture Collection (Manassas, VA, U.S.A.). COS-7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) and MCF-7 cells were cultured in RPMI-1640 medium (Gibco, Rockville, MD, U.S.A.). In routine culture, both cell types were supplemented with 10% fetal bovine serum (FBS) (Gibco, Rockville, MD, U.S.A.) and antibiotics (100 U/ml penicillin A and 100 mg/ml of streptomycin), and stored at 37°C in a humidified incubator containing 5% CO 2 . When cells reached about 80% confluence, the medium was changed to phenol red-free DMEM or RPMI supplemented with 1% charcoal dextran-stripped FBS (csFBS) (Thermo Fisher Scientific, Logan, UT, U.S.A.) for 2 d of hormone starvation. After hormone starvation, cells were ready to use for assays.
Cytotoxicity of Xanthorrhizol on COS-7 and MCF-7 Cells Cell viability was determined by the MTT colorimetric assay (3-[4,5-diethylthiazol-2-yl]-2,5-dipheniltetrazolium bromide; Sigma-Aldrich, St. Louis, MO, U.S.A.) according to the method of Mosmann. After hormone starvation, the cells were seeded at a concentration of 4ϫ10 4 cells/ml in 96-well plates (Microtest 96, Becton Dickinson Co., Franklin Lakes, NJ, U.S.A.) and cultured in phenol red-free DMEMcsFBS at 37°C in a 5% CO 2 atmosphere. After 24 h of attachment, culture medium was discarded and the cells were treated with various concentrations of xanthorrhizol or a combination of xanthorrhizol and ICI 182780 (SigmaAldrich, St. Louis, MO, U.S.A.) in 200 ml serum-free and phenol red-free DMEM or RPMI. The COS-7 cells were treated for 24 h and the MCF-7 cells were treated for 48 h. After treatment, cells were incubated with 50 ml of MTT (1 mg/ml) for 4 h at 37°C. The insoluble formazan dye was solubilized in 200 ml of DMSO and the spectrophotometric absorbance was measured at 550 nm with a tunable microplate reader (Versa Max, Sunnyvale, CA, U.S.A.).
Transient Transfection and Luciferase Ligand Binding Transactivation Assays COS-7 cells were seeded at concentration 1ϫ10 6 cells/ml in 6-well plates in phenol red-free DMEM-csFBS. After seeding, a Gal4 DNA binding domain (DBD)-ERa ligand binding domain (LBD) or Gal4 DBDERb LBD plasmid, pFR-luciferase, and pFR-bgal reporter plasmid were transfected into the cells using Lipofectamine and Plus TM Reagent (Invitrogen, Carlsbad, CA, U.S.A.). After 5 h transfection, the medium was changed to fresh medium containing the indicated amount of experimental treatment. In the MCF-7 experiment, the cells were seeded at concentration 3ϫ10 5 cells/ml into 6-well plates in phenol red-free RPMI-csFBS. An ERE-luciferase plasmid and pFR-bgal plasmid were transfected into the cells using the previously mentioned method. Medium replacement was done after 12 h transfection. After 18 h incubation, cells were lysed and the cell lysates were used in activities measurements. The relative luciferase unit (RLU) was measured using a MicroLumatPlus LB 96V luminometer (Berthold, Wildbad, Germany) and the bgal activity was measured using the 2-nitrophenyl b-D-galactopyranoside (ONPG) method (SigmaAldrich, St. Louis, MO, U.S.A.). Final results were obtained from the RLU normalized against bgal activity. In this experiment, the Gal4-ERa plasmid was a kind gift from Dr. Yoon Kwang Lee (Kent State University, Kent, Ohio, U.S.A.) and the Gal4-ERb and ERE-luciferase plasmids were kindly provided by Dr. Hinrich Gronemeyer (Institute of Genetics and Molecular and Cellular Biology, Illkirch Cedex, France). Both pFR reporter plasmids were purchased from Stratagene (La Jolla, CA, U.S.A.).
Semi-quantitative RT-PCR for pS2 Expression MCF-7 cells were grown in 6-well plates in phenol red-free RPMIcsFBS. Cells were treated with the indicated amount of reagent for 48 h. Total RNA from MCF-7 cells was extracted using Trizol reagent (Invitrogen Corp., Carlsbad, CA, U.S.A.) according to the manufacturer's protocol and quantified spectrophotometrically at 260/280 nm. cDNA was synthesized by using 1 mg total RNA and oligo dT reverse transcriptase premix (Elpis-Biotech, Taejeon, Korea) in a 20 ml total reaction volume. Reverse transcription was performed as follows: 70°C for 5 min, 42°C for 60 min, and 94°C for 5 min. The cDNA products were directly used in PCR reactions conducted using Takara LA Taq polymerase (Takara Bio Inc., Shiga, Japan). The primers used for pS2 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were 5Ј-CACCATGGAGAACAAGGTGA-3Ј (pS2 forward), 5Ј-CC-GAGCTCTGGGACTAATCA-3Ј (pS2 reverse), 5Ј-CAAT-GACCCCTTCATTGACC-3Ј (GAPDH forward), and 5Ј-TGAGTCCTTCCACGATACCA-3Ј (GAPDH reverse) to yield products of 323 and 425 bp, respectively. PCR consisted of 25 amplification cycles of 1 min at 94°C, 1 min at annealing temperature, and 1 min at 72°C in a thermal cycler (Gene Amp PCR System 2700, Applied Biosystems, CA, U.S.A.). The human GAPDH housekeeping gene was used as an internal control. PCR products were separated electrophoretically in a 2% agarose DNA gel and stained with ethidium bromide. The stained gel was visualized by GelDoc Quantity One software (Bio-Rad Laboratories, Hercules, CA, U.S.A.).
Statistical Analysis Triplicate experiments were performed throughout this study. All data are presented as the meanϮstandard deviation (S.D.). The significant difference between the control (DMSO) and treated groups were statistically analyzed by the paired Student's t-test (pϽ0.05). Cells The cytotoxicity of xanthorrhizol on COS-7 and MCF-7 cells was determined by MTT assay. In the COS-7 assay, cells were treated with xanthorrhizol at concentrations ranging from 1-50 mM for 24 h. At these concentrations, xanthorrhizol did not affect the cell viability ( Fig. 2A) . Thus, xanthorrhizol concentrations within this range were used in further COS-7 transactivation assays. In contrast, in the MCF-7 assay, cells demonstrated more sensitivity to xanthorrhizol than COS-7 cells. Xanthorrhizol at 1-7.5 mM resulted in cell viability of more than 80% after incubation for 24 and 48 h (Fig. 2B) . At 1 mM, xanthorrhizol slightly decreased cell viability (Ͻ13%) during a 48 h incubation. Therefore, we used xanthorrhizol at concentrations of 0.5-5 mM for the assays involving MCF-7 cells. Figs. 3A and B, treatment of these cells with xanthorrhizol at various concentrations increased luciferase activity in a dose-dependent manner. In ERa-transfected cells, 10 mM xanthorrhizol induced luciferase activity by about 517% compared to control treatment. Interestingly, luciferase activity was similar to that obtained with 5 mM estradiol (504%) (Fig. 3A) . In ERb transfected cells, 10 mM xanthorrhizol induced luciferase activity by 832% compared with the vehicle (Fig. 3B) . However, this luciferase activity was much lower than obtained with 5 mM estradiol (5783%). Furthermore, to confirm that the agonistic activity of xanthorrhizol was ER-mediated, ERa transfected cells were co-treated with 1 mM ICI 182780. These results showed that the luciferase activity induced by 5 mM xanthorrhizol was completely diminished by ICI 182780 (Fig. 3C) . The quenching of luciferase expression was not a result of reduced cell viability because co-treatment with both agents did not cause COS-7 cell death (Fig. 3D) . These results indicate that the induction of luciferase activity is possibly mediated through ER LBD-ligand interaction.
RESULTS
Cytotoxicity of Xanthorrhizol on COS-7 and MCF-7
Induction of Luciferase Activity by Xanthorrhizol in Transiently Transfected COS-7 Cells
Effects of Xanthorrhizol on ERE Activation and pS2 mRNA Expression in MCF-7 Cells We investigated whether xanthorrhizol activated endogenous ER in MCF-7 cells by transiently transfecting the cells with an ERE-luciferase reporter gene. As seen in Fig. 4A , xanthorrhizol induced ERE-dependent luciferase activity by about 244% at 1 mM 24 h after treatment compared to controls. This result meant that xanthorrhizol could activate the ER-ERE interaction followed by expression of the target gene. In a parallel assay, to show if the original ER gene target in MCF-7 cells can also be induced by xanthorrhizol treatment, the level of pS2 mRNA expression was assayed. As shown in Fig. 4B , after 48 h sample treatment at 1 mM and 5 mM concentrations, the cells increased expression of pS2 mRNA compared to control treatment. This result also confirmed the previous assay result. Finally, co-treatment of transiently transfected MCF-7 cells with 1 mM ICI 182780 could completely abolish both the luciferase activity and pS2 mRNA expression (Figs.  4C, D) . Nevertheless, both of the activities were not abolished due to the cell death. Since, as shown in Fig. 4E , the cell viability under treatment of 1 mM xanthorrhizol combined with 1 mM ICI 182780 was still remaining high (Ͼ80%) and similar with the 48 h treatment of 1 mM xanthorrhizol or ICI 182780 alone. This result implied that xanthorrhizol exerted estrogenic effects through ER binding to ERE.
DISCUSSION
Phytoestrogens, a term coined to describe plant-derived chemicals that exert estrogenic activity, involve numerous va- rieties of structurally diverse compounds and are grouped into isoflavones, stilbenes, coumestans, and lignans. They can regulate the actions of endogenous estrogens, usually by binding to ERs. 28, 29) ER itself is a member of the nuclear receptor superfamily, which acts by regulating the transcription process. The classical pathway of ER action involves ligand binding to receptor in the nucleus, followed by dimerization and binding to specific response elements known as EREs, located in the promoter regions of target genes. 30) In humans, two distinct estrogen receptors, ERa and ERb, can be detected in a broad spectrum of tissues. In some organs, both receptor subtypes are expressed at similar levels, whereas in others, one or the other subtypes predominates. 31) Both ER subtypes have functional differences, depending on the tissue type. For example, ERb has been known for its potential as a tumor suppression gene in breast tissue, while ERa plays an important role in vessel wall pathophysiology in the cardiovascular system. ERa has also been known for playing an important role in postpubertal bone elongation, while ERb is responsible for repression of the ERa-mediated bone growth-promoting effect. Furthermore, in adipocytes, ERa is known to decrease adipose tissue mass by increasing lypolysis. 31) Both ER subtypes bind phytoestrogen, although their binding patterns may vary and their affinities for phytoestrogen are 100-to 10000-fold lower than that of estradiol. 32) Based on recent reviews, phytoestrogens have frequently been tested for their benefits. Phytoestrogens have been known for their ability to improve bone mass and reduce cardiovascular risk factors in postmenopausal woman. 33) Reduced endometrial cancer risk has also been observed among those taking phytoestrogen. Phytoestrogens may also act as antioxidants and inhibit blood vessel growth, essential for tumor expansion (a similar function was also proposed for xanthorrhizol). In Alzheimer's disease research, phytoestrogens showed beneficial effects on memory and central nervous system function. 34) Furthermore, in recent studies, phytoestrogens have been assayed as cosmeceuticals as skin antiaging and anti-carcinogenesis agents. 35, 36) In this study, using the Gal4 fusion reporter system, xanthorrhizol binding interaction to ERs was screened. From our results, we found that xanthorrhizol could interact and saturate the ER ligand binding domain. The saturation was adequate to stimulate the luciferase signal in both ERa and ERb systems. However, due to differences in the reporter plasmids involved in this assay, the levels of luciferase signal from both systems were different. The signals resulting from xanthorrhizol treatment, if compared with estradiol, were far lower in the ERb system than in the ERa system. In previous studies, estradiol itself has been reported to have a lower affinity to ERb than to ERa. [37] [38] [39] Thus, it could be viewed that xanthorrhizol might have a higher affinity for ERa because it stimulated luciferase expression in a dose-dependent manner and reached the same level of luciferase signal produced by 5 mM estradiol at a concentration of 10 mM (Fig.  3A) . Although xanthorrhizol's luciferase signal in the ERb assay was also dose-dependent, and significant relative to controls, the signals were very low compared to that of estradiol (Fig. 3B) . Finally, in the co-treatment assay using the ER antagonist, ICI 182780, signal from the ERa system was completely reversed without affecting the cell viability (Figs.  3C, D) . These results imply that xanthorrhizol exerts its effects through the ER and follows the classical pathway of ER activation.
To prove our hypothesis, xanthorrhizol was also tested in MCF-7 cells, an estrogen positive cell line. 28) Results showed that, xanthorrhizol could enhance expression of both luciferase and pS2 mRNAs compared to controls. However, both signals appeared weaker than that obtained with estradiol treatment (Figs. 4A, C) . This was due to the fact that xanthorrhizol, at the higher concentration range used previously in the MCF-7 assay (1-10 mM) exhibited strong cytotoxic activity. 25) Finally, the up-regulated luciferase and pS2 expressions could be reversed by ICI 182780 co-treatment. The complete reversal of both signals showed that xanthorrhizol exerted its estrogenic activity through the ER in MCF-7 cells.
Our studies show that xanthorrhizol, isolated from C. xanthorrhiza ROXB. has estrogenic activity because it binds to ERs and activates its target genes through the classical ER pathway. This finding expands the potential uses for xanthorrhizol. From preliminary assays, we have determined that xanthorrhizol does not interact with the glucocorticoid receptor (data not shown). Therefore, we will explore if xanthorrhizol may also activate other steroidal hormone receptors (androgen receptor (AR) and mineral receptors (MR)). Furthermore, as a phytoestrogen, it will be determined if xanthorrhizol exhibits direct action on osteoblasts by inducing mineralization and if it has non-genomic estrogenic activity.
